Zhou LiChun, Xiang Wei, Potts James, Floyd Michael, Sharan Chakradhari, Yang Hong, Ross Joan, Nyanda Alfred M, Guo ZhongMao
Division of Cardiovascular Biology, Department of Biomedical Sciences, Meharry Medical College, Nashville, TN 37208, USA.
Free Radic Biol Med. 2006 Nov 1;41(9):1384-91. doi: 10.1016/j.freeradbiomed.2006.07.019. Epub 2006 Jul 27.
Superoxide anions react with nitric oxide to form peroxynitrite and hence reduce the bioavailability of nitric oxide in the arteries. Extracellular superoxide dismutase (EC-SOD) is a major superoxide scavenger in human plasma and vascular tissues. The objective of this study is to assess whether essential hypertension is associated with an alteration in EC-SOD activity. In this report, blood samples were obtained from hypertensive (n=39) and normotensive (n=37) African-Americans. Plasma EC-SOD activity was measured using in-gel activity staining and spectrophotometric assays, EC-SOD protein level was measured using Western blotting, nitrotyrosine was measured using slot blotting, 8-isoprostane was measured with an enzyme immunoassay, and plasma copper and zinc concentrations were measured using an atomic absorption assay. Our data demonstrate that the copper, zinc, and plasma EC-SOD protein concentrations in the hypertensive and normotensive subjects are indistinguishable. Compared to normotensive controls, hypertensive patients have significantly reduced plasma EC-SOD activity. Plasma nitrotyrosine and 8-isoprostane levels are significantly higher in the hypertensive patients than in normotensive controls. Results from this study suggest that a reduction in EC-SOD activity in hypertensive patients is not due to a down-regulation of the SOD3 gene (encoding EC-SOD) or deficiency in mineral cofactors. Furthermore, the reduced EC-SOD activity might be at least partially responsible for the increased oxidative stress, as reflected by increased plasma nitrotyrosine and 8-isoprostane, in hypertensive subjects.
超氧阴离子与一氧化氮反应形成过氧亚硝酸盐,从而降低动脉中一氧化氮的生物利用度。细胞外超氧化物歧化酶(EC-SOD)是人体血浆和血管组织中的主要超氧化物清除剂。本研究的目的是评估原发性高血压是否与EC-SOD活性改变有关。在本报告中,从高血压(n = 39)和血压正常(n = 37)的非裔美国人中采集血样。使用凝胶内活性染色和分光光度法测定血浆EC-SOD活性,使用蛋白质印迹法测定EC-SOD蛋白水平,使用狭缝印迹法测定硝基酪氨酸,使用酶免疫测定法测定8-异前列腺素,并使用原子吸收测定法测定血浆铜和锌浓度。我们的数据表明,高血压和血压正常受试者的铜、锌和血浆EC-SOD蛋白浓度没有差异。与血压正常的对照组相比,高血压患者的血浆EC-SOD活性显著降低。高血压患者的血浆硝基酪氨酸和8-异前列腺素水平显著高于血压正常的对照组。本研究结果表明,高血压患者EC-SOD活性降低并非由于SOD3基因(编码EC-SOD)下调或矿物质辅因子缺乏。此外,EC-SOD活性降低可能至少部分导致了高血压患者氧化应激增加,这表现为血浆硝基酪氨酸和8-异前列腺素增加。